K2 Principal Fund, L.P. Pasithea Therapeutics Corp. Transaction History

K2 Principal Fund, L.P.

  • $197 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
SELL
$0.55 - $26.0 $115,148 - $5.44 Million
-209,360 Reduced 42.57%
282,437 $180,000
Q2 2022

Aug 12, 2022
SELL
$16.52 - $27.0 $961,513 - $1.57 Million
-58,203 Reduced 10.58%
491,797 $497,000
Q4 2021

Feb 11, 2022
BUY
$28.8 - $112.0 $15.8 Million - $61.6 Million
550,000 New
550,000 $973,000

About Pasithea Therapeutics Corp.

KTTA Quotes by TradingView
  • Ticker KTTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,398,700
  • Market Cap $157M
  • Description
  • Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 ...
More about KTTA
Track This Portfolio

Track K2 Principal Fund, L.P. Portfolio

Follow K2 Principal Fund, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of K2 Principal Fund, L.P., based on Form 13F filings with the SEC.

News

Stay updated on K2 Principal Fund, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email